A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung diseaseMasaki Hanibuchi, Yasuhiko Nishioka, Soji Kakiuchi et al.|Lung Cancer|2018Cited by 31
Analysis of acute exacerbation of interstitial lung disease associated with chemotherapy in patients with lung cancer: A feasibility of S-1Soji Kakiuchi, Yasuhiko Nishioka, Masaki Hanibuchi et al.|Respiratory Investigation|2016Cited by 27
FK506 and cyclosporin A inhibit granulocyte/macrophage colony-stimulating factor production by mononuclear cells in asthmaTakeshi Sano, Takehiko Ogura, Youichi Nakamura et al.|European Respiratory Journal|1995Cited by 21
Phase II study of tailored S-1 monotherapy with a 1-week interval after a 2-week dosing period in elderly patients with advanced non-small cell lung cancerHisatsugu Goto, Yasuhiko Nishioka, Yoshio Okano et al.|Respiratory Investigation|2017Cited by 13
A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancerHideki Tomimoto, Saburo Sone, Masaki Hanibuchi et al.|Oncology Letters|2011Cited by 3